Bombard Allan

Avg. Two Year Performance

(42%) Avg. Purchase Return
(19%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return14%17%6%11%(42%)
Purchase Success Rate2 of 22 of 21 of 21 of 20 of 2
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

Chief Medical Officer:

Holdings: 52.73K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--